Nasdaq
$5.01▼ 0.40%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $107.9MShares out 21.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
4- 10.9Regular26.10.10 04:35SCHEDULE 13G/AOwnership#●●●
Journey Medical Corp
This is a SCHEDULE 13G/A filing regarding the beneficial ownership of Journey Medical Corp by Wasatch Advisors LP. The reporting entity has updated its holdings in the company, reflecting changes in its position.…more
$5.01-0.40%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.12After-hours26.08.13 05:4010-QEarnings
Journey Medical Corp
Journey Medical Corporation (DERM) filed its quarterly report (10-Q) for the period ended June 30, 2026. As of the quarter-end, the company reported cash and cash equivalents of $25.643 million and accounts receivable of $36.246 million.…more
$5.01-0.40%vs prev closeView filingShare - 8.12After-hours26.08.13 05:058-KKey event
Journey Medical Corp
Journey Medical reported total revenue of $18.5 million for the second quarter of 2026, representing a 23% increase year-over-year, while net loss narrowed significantly to $0.312 million ($0.01 per share). The company's key product, Emrosi, generated $8.1 million in revenue, and management continues to drive profitability through disciplined cost management and revenue growth.…more
$5.01-0.40%vs prev closeView filingShare
3 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.8After-hours26.09.09 05:05#●●●#●●●
Journey Medical to Participate in September Investor Conferences
Journey Medical Corporation announced that its management will participate in two investor conferences in September 2026. These events involve presentations and meetings, which are standard corporate outreach activities.…more
$5.01-0.40%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 8.12After-hours26.08.13 05:01
●●●●●●●● ●●●●● ●●●●●●
Journey Medical reported Q2 revenue of $18.5 million, marking a 23% year-over-year increase and continued progress toward profitability. Growth was driven by strong prescription demand for its flagship product, Emrosi.…more
$5.01-0.40%vs prev close - 8.5Pre-market26.08.05 21:30
●●●●●●●● ●●●●● ●●●●●●
저니 메디컬이 오는 8월 12일 장 마감 후 2026년 2분기 재무 실적을 발표할 예정입니다. 실적 발표와 함께 경영진의 기업 업데이트가 진행될 예정으로 투자자들의 관심이 집중됩니다.…more
$5.01-0.40%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report